JAMA Neurology

08/18/2025

📢 In this podcast episode, author Colin Derdeyn, MD, of School of Medicine at the University of Virginia discusses treatment of acute ischemic stroke and more, with JAMA Neurology Web Editor Cynthia Armand.

🔗 Listen now:

Interview with Colin P. Derdeyn, MD, author of Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD.

08/18/2025

Adding argatroban or eptifibatide to intravenous thrombolysis did not improve reperfusion rates or clinical outcomes in endovascular thrombectomy for acute ischemic stroke. https://ja.ma/41apQH7

08/18/2025

Most viewed this week from JAMA Neurology: Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma.

https://ja.ma/45QzMYO

08/17/2025

Images in Neurology: An eight-year-old girl was seen in a clinic for cerebrospinal fluid (CSF) rhinorrhea, orthostatic headaches, and an acquired Chiari malformation. https://ja.ma/4fqYwu6

08/16/2025

No evidence was found for a new neurological disease in New Brunswick, Canada, as previously misdiagnosed well-known conditions were responsible for the symptoms.

https://ja.ma/45DAEyS

08/16/2025

Most viewed this week from JAMA Neurology: Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma.

https://ja.ma/4milJB6

08/15/2025

Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally. https://ja.ma/4lengGY

08/14/2025

In patients with multiple sclerosis, chronic lesion development begins early in the disease course, even with effective treatment.

https://ja.ma/3HrtEgw

08/13/2025

Case report: a 61-year-old man with alcohol use disorder presented with altered consciousness and vision loss after ceasing alcohol consumption. https://ja.ma/4fAs60b

08/13/2025

Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally. https://ja.ma/3J4TwPF

08/12/2025

Male patients with have higher mortality rates and greater use of health care services, particularly hospitalizations, compared to female patients. https://ja.ma/4otO6hu

08/11/2025

Despite a decrease in age-standardized rates, subarachnoid hemorrhage remains one of the most common cardiovascular and neurological causes of death and disability globally. https://ja.ma/3Hmgxgo